Investigating the Safety and Clinical Performance of Eight iVascular Devices for Endovascular Intervention in Renal, Iliac or Femoral Arteries

Who May Qualify: - Corresponding to the CE-mark indications/contra-indications and according to the IFU of the device. - Patient is \>18 years old. - Patient understands the nature of the procedure and provides written willing to sign a consent form prior to enrollment in the study. - Target lesion(s) is/are located in renal, iliac or femoral arteries. - Patient is eligible for treatment with the Oceanus 18 Balloon Dilatation Catheter and/or the Oceanus 35 Balloon Dilatation Catheter and/or the Luminor 18 Drug Coated Balloon and/or the Luminor 35 Drug Coated Balloon and/or the Restorer Peripheral Stent System and/or the iVolution pro Peripheral Self-Expanding Stent System and/or the iCover Covered Peripheral Stent System and/or the Sergeant Peripheral Support Catheter as described in IFU for each device. Who Should NOT Join This Trial: - Anatomy or size of vessels that will not allow appropriate usage of the investigational devices, following IFU of the investigational devices. - Known contraindication and/or allergy to (a component of) an investigational device. - Pregnant women and women with childbearing potential not taking adequate contraceptives or currently breastfeeding. - Life expectancy of less than 12 months. - Any planned surgical intervention/procedure within 30 days after the study procedure. - Any patient considered to be hemodynamically unstable at onset of the procedure. Always talk to your doctor about whether this trial is right for you.